Estimating the Impact of the Inflation Reduction Act on the Out-of-pocket Costs for Medicare Beneficiaries With Advanced Prostate Cancer.
Brian D CorteseStacie B DusetzinaBashir Al Hussein Al AwamlhDavid F PensonSam S ChangDaniel A BarocasAmy N LuckenbaughKristen R ScarpatoKelvin A MosesRuchika TalwarPublished in: Urology practice (2023)
The $2,000 spending cap introduced by the Inflation Reduction Act may significantly decrease out-of-pocket costs and reduce financial toxicity associated with advanced prostate cancer treatment, impacting an estimated 25,000 Medicare beneficiaries.